Analysis of discourse production among speakers with acquired communication disorders is an important and necessary clinical procedure. This book provides a comprehensive review and discussion of aphasia and its related disorders, their corresponding clinical discourse symptoms that speech-and-language pathologists should address, and the different methods of discourse elicitation that are clinically and research oriented. This edition has been thoroughly updated throughout to include the latest research, including advances in word retrieval and discourse production, cognitive and multicultural aspects of disordered discourse production, application of technology to understand and evaluate spoken discourse, and evidence-based intervention of discourse impairments. Contemporary issues related to disordered/clinical discourse elicitation are added. Recent advancement in discourse analysis is covered and discussions of various treatment options of discourse symptoms are provided. Finally, the manifestation of discourse symptoms as a function of speakers’ multilingual/multi-cultural status and specific considerations related to clinical assessment and remediation are explored. As the only introductory text to include comprehensive coverage of basic knowledge of neurogenic disordered discourse, it is a must-read for students, clinicians, and researchers in various fields. Readers will also benefit from plenty of examples that provide a connection between the theoretical contents presented in the text and application to real-life contexts of discourse production.

Analysis of Neurogenic Disordered Discourse Production provides a comprehensive review and discussion of aphasia and its related disorders, their corresponding clinical discourse symptoms that speech-language pathologists and related healthcare professionals should address, and the different methods of discourse elicitation that are research- and clinically-oriented. Contemporary issues related to disordered/clinical discourse production are covered, and discussions of various treatment options in relation to discourse symptoms are included. Finally, the manifestation of discourse symptoms as a function of speakers’ bilingual/multilingual status and specific considerations related to clinical assessment and intervention are explored. Readers who want to learn the background and techniques of discourse analysis, refresh their knowledge of discourse production, update their knowledge of assessment and treatment of discourse production, and learn about contemporary issues of discourse annotation and analysis using existing computer software will find this book a valuable tool. With its comprehensive coverage, it offers a thorough understanding of the nature, assessment, and remediation of discourse deficits in aphasia and related disorders. Readers will also benefit from examples throughout the book that connect theory to real-life contexts of discourse production.

Analysis of Neurogenic Disordered Discourse Production provides a comprehensive review and discussion of aphasia and its related disorders, their corresponding clinical discourse symptoms that speech-language pathologists and related healthcare professionals should address, and the different methods of discourse elicitation that are research- and clinically-oriented. Contemporary issues related to disordered/clinical discourse production are covered, and discussions of various treatment options in relation to discourse symptoms are included. Finally, the manifestation of discourse symptoms as a function of speakers’ bilingual/multilingual status and specific considerations related to clinical assessment and intervention are explored. Readers who want to learn the background and techniques of discourse analysis, refresh their knowledge of discourse production, update their knowledge of assessment and treatment of discourse production, and learn about contemporary issues of discourse annotation and analysis using existing computer software will find this book a valuable tool. With its comprehensive coverage, it offers a thorough understanding of the nature, assessment, and remediation of discourse deficits in aphasia and related disorders. Readers will also benefit from examples throughout the book that connect theory to real-life contexts of discourse production.

This comprehensive volume provides balanced and easily readable chapters on contemporary topics around discourse production in patients with neurogenic disorders. Discourse broadly refers to a unit of language longer than a single sentence, typically used in a spoken or written format to express ideas, feelings, and opinions or to interact with others. As the field of research in speech-language pathology, aphasia and related neurogenic disorders, and clinical decision-making to manage neurogenic impairments is rapidly expanding, there has been an increased focus on discourse analysis and therapy to enable patients to speak well again. Various user groups and people with lived experience (e.g., aphasia, dementia, traumatic brain injury, right hemisphere damage, etc.) are also increasingly focused on the impact of neurogenic impairments on domains of conversation and changes in language skills beyond the smaller linguistic components of single words and sentences that are traditionally supported by speech-language therapy. The first part of this book details and discusses the basic principles, historical perspectives (history and developmental milestones), neural basis, and recent evolutions and advancement of discourse analysis in speakers with acquired communication disorders. The second part of the book outlines and illustrates current methods for discourse elicitation and analysis across different clinical populations. Recent leaps forward in technology that can assist in the recording, processing, and analysis of discourse will be highlighted. The final part of book reviews and summarizes key developments of various evidenced-based training strategies, interventions, and treatment programs, as well as utilization of innovative technology to clinically improve neurogenic disordered discourse.​ This is an ideal guide for researchers, clinicians, and students in the field of communication sciences and disorders, speech and language therapy, gerontology, (neuro-)linguistics, psychology, and related fields in clinical medicine.

Discourse Analysis in Adults With and Without Communication Disorders: A Resource for Clinicians and Researchers provides state-of-the-art information about discourse analysis with sections on Aging, Aphasia, Cognitive Communication Disorders, and Neurodegenerative Diseases. The three renowned editors are actively engaged in the area of discourse. Expert clinical researchers introduce and organize each section, and chapters are authored by leaders involved in discourse research worldwide. Discourse is considered the most natural unit of language. Effective production of discourse requires complex interactions among linguistic, cognitive, and social abilities that are sensitive to even mild disruption in any one of these elements. This book covers the examination of discourse in adults with acquired communication disorders, including selecting elicitation tasks, streamlining transcription processes, expanding analysis methods, and translating findings for treatment application. Key Features * Provides a global perspective on discourse assessment for clinicians * Dedicated chapters on aging, aphasia, traumatic brain injury, right hemisphere disorder, primary progressive aphasia, Alzheimer’s dementia, Parkinson’s disease, and amyotrophic lateral sclerosis Disclaimer: Please note that ancillary content (such as documents, audio, and video, etc.) may not be included as published in the original print version of this book.

Major neurocognitive disorders are one of the leading causes of disability and dependency among the elderly worldwide. Notably, their far-reaching impact extends beyond the estimated 50 million people currently living with a major neurocognitive disorder. As the conversion to Alzheimer's disease (AD) progresses, patients’ symptoms (e.g., memory loss, severe impairments in thinking and behavior) place a heavy toll on their caregivers, family, and friends, who face emotional frustration, coupled with great financial stress. Furthermore, in terms of global cost estimation, the World Health Organization predicted that by 2030, the treatment of patients with AD and other forms of acquired cognitive impairment will cost the healthcare system US$1.7 trillion (or US$2.8 trillion, if corrected for the increase in care costs).